logo BDSP

Base documentaire

  1. Fasting plasma glucose and subsequent macrovascular disease after 10 years follow-up : a collaborative study on two populations.

    Article - En anglais

    The American Diabetes Association recently proposed a new, lower, cut-point of 7.0 mmol/l for diagnosis of diabetes mellitus.

    We examined data from the Caerphilly and Speedwell cohorts to determine possible cut-points of fasting plasma glucose for increased risk of subsequent ischaemic heart disease (IHD).

    Men (n=4860) from the general population of a town in South Wales and a practice-based population in Bristol aged 45-63 years were first examined in 1979-83, and re-examined at intervals, and these data relate to follow-up at about 10 years (120 months, Caerphilly) (112 months, Speedwell).

    Clinically recognized diabetics (n=94) experienced a higher mortality rate and an excess number of major IHD events.

    Among non-diabetics, mean blood glucose was 5.0 mmol/l and a significant excess of major IHD events occurred above this point even when the data were fully adjusted for all other IHD risk factors.

    Risk of major IHD was greatest for non-diabetic men with plasma glucose levels between 7.0 and 7.7 mmol/l. Under 7.0 mmol/l, the excess event rate was modest, however.

    Glucose levels were not associated with excess all-cause mortality among these non-diabetic men.

    These data, based on the excess risk of macrovascular disease experienced by a British cohort of non-diabetic men, accord with the proposals to base the diagnosis of diabetes on a cut point of 7.0 rather than 7.8 mmol/l.

    Mots-clés Pascal : Diabète, Etude longitudinale, Jeûne alimentaire, Glucose, Plasma, Etude comparative, Analyse biochimique, Facteur risque, Complication, Royaume Uni, Europe, Homme, Etude cohorte, Endocrinopathie, Biologie moléculaire, Prévention

    Mots-clés Pascal anglais : Diabetes mellitus, Follow up study, Fasting, Glucose, Plasma, Comparative study, Biochemical analysis, Risk factor, Complication, United Kingdom, Europe, Human, Cohort study, Endocrinopathy, Molecular biology, Prevention

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0236061

    Code Inist : 002B21E01A. Création : 16/11/1999.